Review



160 gd conjugated mouse anti human cd14  (fluidigm)


Bioz Verified Symbol fluidigm is a verified supplier
Bioz Manufacturer Symbol fluidigm manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    fluidigm 160 gd conjugated mouse anti human cd14
    Peripheral blood mononuclear cells from P. vivax symptomatic ( n = 8), asymptomatic ( n = 8), and healthy controls ( n = 8) were stained with a panel of metal-labeled antibodies and analyzed CyTOF. ( A ) Manual gating was used to select for <t>CD14</t> + monocytes. ( B ) vi-SNE analysis was performed on pooled monocytes for each group and the cell surface expression was illustrated by their density.
    160 Gd Conjugated Mouse Anti Human Cd14, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+cd14+160/Anti-Human+CD14+(RMO52)-160Gd/pmc12583509-58-0-6
    Average 93 stars, based on 14 article reviews
    160 gd conjugated mouse anti human cd14 - by Bioz Stars, 2026-10
    93/100 stars

    Images

    1) Product Images from "Systems approach identifies monocyte imbalance in symptomatic and asymptomatic P. vivax malaria"

    Article Title: Systems approach identifies monocyte imbalance in symptomatic and asymptomatic P. vivax malaria

    Journal: Molecular Systems Biology

    doi: 10.1038/s44320-025-00135-z

    Peripheral blood mononuclear cells from P. vivax symptomatic ( n = 8), asymptomatic ( n = 8), and healthy controls ( n = 8) were stained with a panel of metal-labeled antibodies and analyzed CyTOF. ( A ) Manual gating was used to select for CD14 + monocytes. ( B ) vi-SNE analysis was performed on pooled monocytes for each group and the cell surface expression was illustrated by their density.
    Figure Legend Snippet: Peripheral blood mononuclear cells from P. vivax symptomatic ( n = 8), asymptomatic ( n = 8), and healthy controls ( n = 8) were stained with a panel of metal-labeled antibodies and analyzed CyTOF. ( A ) Manual gating was used to select for CD14 + monocytes. ( B ) vi-SNE analysis was performed on pooled monocytes for each group and the cell surface expression was illustrated by their density.

    Techniques Used: Staining, Labeling, Expressing

    ( A – F ) PBMCs from P. vivax symptomatic ( n = 8) and asymptomatic ( n = 8) infected individuals as well as healthy immune controls ( n = 8) were stained with a panel of metal-labeled antibodies and analyzed by CyTOF. ( A ) t-SNE analysis was performed on CD14 + CD3 - CD29 - monocytes. Plots display cell density and represent the pooled data for each group. ( B ) Projection of FlowSOM clusters on a t-SNE plot. ( C ) Heatmaps show the median marker expression for each FlowSOM cluster. ( D – F ) Unsupervised identification of differentially abundant populations between clinical groups was performed using CITRUS (FDR < 5%) between clinical groups. Panels on the top left or each panel show differentially abundant populations on a t-SNE overlay identified as follows: significantly more abundant in symptomatic individuals compared to healthy immune controls ( D ), significantly more abundant in symptomatic and asymptomatic individuals compared to healthy immune controls ( E ) and significantly depleted in symptomatic and asymptomatic individuals compared to healthy immune controls ( F ). vi-SNE plots on the top right-hand side or each top panel depict relevant marker expression on t-SNE overlays. The lower left panels show the frequency of differentially abundant cell populations identified by CITRUS. Boxes represent the 25th to 75th percentile, whiskers show the range (minimum to maximum), and lines represent the median of 8 symptomatic, 8 asymptomatic, and 8 healthy immune control biological replicates. The lower right panels illustrate marker expression in differentially abundant populations (pink histograms), relative to background expression (lilac histograms).
    Figure Legend Snippet: ( A – F ) PBMCs from P. vivax symptomatic ( n = 8) and asymptomatic ( n = 8) infected individuals as well as healthy immune controls ( n = 8) were stained with a panel of metal-labeled antibodies and analyzed by CyTOF. ( A ) t-SNE analysis was performed on CD14 + CD3 - CD29 - monocytes. Plots display cell density and represent the pooled data for each group. ( B ) Projection of FlowSOM clusters on a t-SNE plot. ( C ) Heatmaps show the median marker expression for each FlowSOM cluster. ( D – F ) Unsupervised identification of differentially abundant populations between clinical groups was performed using CITRUS (FDR < 5%) between clinical groups. Panels on the top left or each panel show differentially abundant populations on a t-SNE overlay identified as follows: significantly more abundant in symptomatic individuals compared to healthy immune controls ( D ), significantly more abundant in symptomatic and asymptomatic individuals compared to healthy immune controls ( E ) and significantly depleted in symptomatic and asymptomatic individuals compared to healthy immune controls ( F ). vi-SNE plots on the top right-hand side or each top panel depict relevant marker expression on t-SNE overlays. The lower left panels show the frequency of differentially abundant cell populations identified by CITRUS. Boxes represent the 25th to 75th percentile, whiskers show the range (minimum to maximum), and lines represent the median of 8 symptomatic, 8 asymptomatic, and 8 healthy immune control biological replicates. The lower right panels illustrate marker expression in differentially abundant populations (pink histograms), relative to background expression (lilac histograms).

    Techniques Used: Infection, Staining, Labeling, Marker, Expressing, Control

    Related Articles

    Staining:

    Article Title: Stratification of Adult Glioblastoma with Signaling and Single Cell Biology
    Article Snippet: The cells were washed and resuspended in staining medium [CSM: PBS + 1% BSA (Fisher Scientific, Fair Lawn, NJ)]. .. Cells were then stained with a mass cytometry antibody panel of 29 extracellular antibodies designed to characterize AML blasts and most non-AML peripheral blood mononuclear cells consisting of anti-human CD235a-141 (clone HIR2, Fluidigm), anti-human CD117-143 (clone 104D2, Fluidigm), anti-human CD11b-144 (clone ICRF 44, Fluidigm), anti-human CD4-145 (clone RPAT4, Fluidigm), anti-human CD64-146 (clone 10.1, Fluidigm), anti-human CD36-147 (clone 5-271, BioLegend), anti- human CD34-148 (clone 581, Fluidigm), anti-human CCR2-149 (clone KO36C2, BioLegend), anti-human CD43- 150 (clone 84-3C1, Fluidigm), antihuman CD123-151 (clone 6H6, Fluidigm), anti-human CD13-152 (clone WM15, Fluidigm), anti-human CD45RA-153 (clone HI100, Fluidigm), anti-human CD45-154 (clone HI30, Fluidigm), anti-human CD86-156 (clone IT2.2, Fluidigm), antihuman CD33-158 (clone WM53, Fluidigm), anti- human CD11c-159 (clone BU15, Fluidigm), anti-human CD14-160 (clone M5E2, Fluidigm), anti-human CD32- 161 (clone FUN-2, BioLegend), anti-human CDHLA-DR-163 (clone L243, BioLegend), anti-human CD15-164 (clone W6D3, Fluidigm), anti-human CD16-165 (clone 3G8, Fluidigm), anti-human CD38-167 (clone HIT2, Fluidigm), anti-human CD8-168 (clone SK1, Fluidigm), anti-human CD25-169 (clone 2A3, Fluidigm), antihuman CD3-170 (clone UCHT1, Fluidigm), anti-human CD184-173 (clone 12G5, Fluidigm), anti-human PD1-174 (clone EH12.2H7, Fluidigm), anti-human PD-L1-175 (clone 29E.2A3, Fluidigm), and anti-human CD56-176 (clone CMSSB, Fluidigm) 50. .. Following permeabilization, cells were washed, stained with 250 nM iridium intercalator (Fluidigm, South San Francisco, CA) for 30 min at 4 °C, washed twice in PBS, and then resuspended in 500 uL of ddH20 for CyTOF analysis.

    Article Title: Discovery of human cell selective effector molecules using single cell multiplexed activity metabolomics
    Article Snippet: The cells were washed and resuspended in staining medium [CSM: PBS + 1% BSA (Fisher Scientific, Fair Lawn, NJ)]. .. Cells were then stained with a mass cytometry antibody panel of 29 extracellular antibodies designed to characterize AML blasts and most non-AML peripheral blood mononuclear cells consisting of anti-human CD235a-141 (clone HIR2, Fluidigm), anti-human CD117-143 (clone 104D2, Fluidigm), anti-human CD11b-144 (clone ICRF44, Fluidigm), anti-human CD4-145 (clone RPAT4, Fluidigm), anti-human CD64-146 (clone 10.1, Fluidigm), anti-human CD36-147 (clone 5-271, BioLegend), anti-human CD34-148 (clone 581, Fluidigm), anti-human CCR2-149 (clone K036C2, BioLegend), anti-human CD43-150 (clone 84-3C1, Fluidigm), anti-human CD123-151 (clone 6H6, Fluidigm), anti-human CD13-152 (clone WM15, Fluidigm), anti-human CD45RA-153 (clone HI100, Fluidigm), anti-human CD45-154 (clone HI30, Fluidigm), anti-human CD86-156 (clone IT2.2, Fluidigm), anti-human CD33-158 (clone WM53, Fluidigm), anti-human CD11c-159 (clone BU15, Fluidigm), anti-human CD14-160 (clone M5E2, Fluidigm), anti-human CD32-161 (clone FUN-2, BioLegend), anti-human CDHLA-DR-163 (clone L243, BioLegend), anti-human CD15-164 (clone W6D3, Fluidigm), anti-human CD16-165 (clone 3G8, Fluidigm), anti-human CD38-167 (clone HIT2, Fluidigm), anti-human CD8-168 (clone SK1, Fluidigm), anti-human CD25-169 (clone 2A3, Fluidigm), anti-human CD3-170 (clone UCHT1, Fluidigm), anti-human CD184-173 (clone 12G5, Fluidigm), anti-human PD1-174 (clone EH12.2H7, Fluidigm), anti-human PD-L1-175 (clone 29E.2A3, Fluidigm), and anti-human CD56-176 (clone CMSSB, Fluidigm) . ..

    Mass Cytometry:

    Article Title: Stratification of Adult Glioblastoma with Signaling and Single Cell Biology
    Article Snippet: The cells were washed and resuspended in staining medium [CSM: PBS + 1% BSA (Fisher Scientific, Fair Lawn, NJ)]. .. Cells were then stained with a mass cytometry antibody panel of 29 extracellular antibodies designed to characterize AML blasts and most non-AML peripheral blood mononuclear cells consisting of anti-human CD235a-141 (clone HIR2, Fluidigm), anti-human CD117-143 (clone 104D2, Fluidigm), anti-human CD11b-144 (clone ICRF 44, Fluidigm), anti-human CD4-145 (clone RPAT4, Fluidigm), anti-human CD64-146 (clone 10.1, Fluidigm), anti-human CD36-147 (clone 5-271, BioLegend), anti- human CD34-148 (clone 581, Fluidigm), anti-human CCR2-149 (clone KO36C2, BioLegend), anti-human CD43- 150 (clone 84-3C1, Fluidigm), antihuman CD123-151 (clone 6H6, Fluidigm), anti-human CD13-152 (clone WM15, Fluidigm), anti-human CD45RA-153 (clone HI100, Fluidigm), anti-human CD45-154 (clone HI30, Fluidigm), anti-human CD86-156 (clone IT2.2, Fluidigm), antihuman CD33-158 (clone WM53, Fluidigm), anti- human CD11c-159 (clone BU15, Fluidigm), anti-human CD14-160 (clone M5E2, Fluidigm), anti-human CD32- 161 (clone FUN-2, BioLegend), anti-human CDHLA-DR-163 (clone L243, BioLegend), anti-human CD15-164 (clone W6D3, Fluidigm), anti-human CD16-165 (clone 3G8, Fluidigm), anti-human CD38-167 (clone HIT2, Fluidigm), anti-human CD8-168 (clone SK1, Fluidigm), anti-human CD25-169 (clone 2A3, Fluidigm), antihuman CD3-170 (clone UCHT1, Fluidigm), anti-human CD184-173 (clone 12G5, Fluidigm), anti-human PD1-174 (clone EH12.2H7, Fluidigm), anti-human PD-L1-175 (clone 29E.2A3, Fluidigm), and anti-human CD56-176 (clone CMSSB, Fluidigm) 50. .. Following permeabilization, cells were washed, stained with 250 nM iridium intercalator (Fluidigm, South San Francisco, CA) for 30 min at 4 °C, washed twice in PBS, and then resuspended in 500 uL of ddH20 for CyTOF analysis.

    Article Title: Discovery of human cell selective effector molecules using single cell multiplexed activity metabolomics
    Article Snippet: The cells were washed and resuspended in staining medium [CSM: PBS + 1% BSA (Fisher Scientific, Fair Lawn, NJ)]. .. Cells were then stained with a mass cytometry antibody panel of 29 extracellular antibodies designed to characterize AML blasts and most non-AML peripheral blood mononuclear cells consisting of anti-human CD235a-141 (clone HIR2, Fluidigm), anti-human CD117-143 (clone 104D2, Fluidigm), anti-human CD11b-144 (clone ICRF44, Fluidigm), anti-human CD4-145 (clone RPAT4, Fluidigm), anti-human CD64-146 (clone 10.1, Fluidigm), anti-human CD36-147 (clone 5-271, BioLegend), anti-human CD34-148 (clone 581, Fluidigm), anti-human CCR2-149 (clone K036C2, BioLegend), anti-human CD43-150 (clone 84-3C1, Fluidigm), anti-human CD123-151 (clone 6H6, Fluidigm), anti-human CD13-152 (clone WM15, Fluidigm), anti-human CD45RA-153 (clone HI100, Fluidigm), anti-human CD45-154 (clone HI30, Fluidigm), anti-human CD86-156 (clone IT2.2, Fluidigm), anti-human CD33-158 (clone WM53, Fluidigm), anti-human CD11c-159 (clone BU15, Fluidigm), anti-human CD14-160 (clone M5E2, Fluidigm), anti-human CD32-161 (clone FUN-2, BioLegend), anti-human CDHLA-DR-163 (clone L243, BioLegend), anti-human CD15-164 (clone W6D3, Fluidigm), anti-human CD16-165 (clone 3G8, Fluidigm), anti-human CD38-167 (clone HIT2, Fluidigm), anti-human CD8-168 (clone SK1, Fluidigm), anti-human CD25-169 (clone 2A3, Fluidigm), anti-human CD3-170 (clone UCHT1, Fluidigm), anti-human CD184-173 (clone 12G5, Fluidigm), anti-human PD1-174 (clone EH12.2H7, Fluidigm), anti-human PD-L1-175 (clone 29E.2A3, Fluidigm), and anti-human CD56-176 (clone CMSSB, Fluidigm) . ..



    Similar Products

    93
    fluidigm 160 gd conjugated mouse anti human cd14
    Peripheral blood mononuclear cells from P. vivax symptomatic ( n = 8), asymptomatic ( n = 8), and healthy controls ( n = 8) were stained with a panel of metal-labeled antibodies and analyzed CyTOF. ( A ) Manual gating was used to select for <t>CD14</t> + monocytes. ( B ) vi-SNE analysis was performed on pooled monocytes for each group and the cell surface expression was illustrated by their density.
    160 Gd Conjugated Mouse Anti Human Cd14, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+cd14+160/Anti-Human+CD14+(RMO52)-160Gd/pmc12583509-58-0-6
    Average 93 stars, based on 1 article reviews
    160 gd conjugated mouse anti human cd14 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    94
    fluidigm cd14 160 gd
    Peripheral blood mononuclear cells from P. vivax symptomatic ( n = 8), asymptomatic ( n = 8), and healthy controls ( n = 8) were stained with a panel of metal-labeled antibodies and analyzed CyTOF. ( A ) Manual gating was used to select for <t>CD14</t> + monocytes. ( B ) vi-SNE analysis was performed on pooled monocytes for each group and the cell surface expression was illustrated by their density.
    Cd14 160 Gd, supplied by fluidigm, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+cd14+160/Anti-Human+CD14+(M5E2)-160Gd/pmc08543755-99-27-52
    Average 94 stars, based on 1 article reviews
    cd14 160 gd - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    fluidigm 3159001b 160 gd cd14 m5e2 fluidigm fluidigm
    Peripheral blood mononuclear cells from P. vivax symptomatic ( n = 8), asymptomatic ( n = 8), and healthy controls ( n = 8) were stained with a panel of metal-labeled antibodies and analyzed CyTOF. ( A ) Manual gating was used to select for <t>CD14</t> + monocytes. ( B ) vi-SNE analysis was performed on pooled monocytes for each group and the cell surface expression was illustrated by their density.
    3159001b 160 Gd Cd14 M5e2 Fluidigm Fluidigm, supplied by fluidigm, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+cd14+160/Anti-Human+CD11c+(Bu15)-159Tb/pmc07688332__abd5575_SM-94-187-192
    Average 94 stars, based on 1 article reviews
    3159001b 160 gd cd14 m5e2 fluidigm fluidigm - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    93
    fluidigm cd14 160 gd m5e2
    KEY RESOURCES TABLE
    Cd14 160 Gd M5e2, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+cd14+160/Anti-Human+CD14+(M5E2)-151Eu/pmc06354585-60-0-6
    Average 93 stars, based on 1 article reviews
    cd14 160 gd m5e2 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    94
    fluidigm anti human cd14 160
    KEY RESOURCES TABLE
    Anti Human Cd14 160, supplied by fluidigm, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+cd14+160/Anti-Human+CD14+(M5E2)-160Gd/pmc05750220-269-108-112
    Average 94 stars, based on 1 article reviews
    anti human cd14 160 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    Image Search Results


    Peripheral blood mononuclear cells from P. vivax symptomatic ( n = 8), asymptomatic ( n = 8), and healthy controls ( n = 8) were stained with a panel of metal-labeled antibodies and analyzed CyTOF. ( A ) Manual gating was used to select for CD14 + monocytes. ( B ) vi-SNE analysis was performed on pooled monocytes for each group and the cell surface expression was illustrated by their density.

    Journal: Molecular Systems Biology

    Article Title: Systems approach identifies monocyte imbalance in symptomatic and asymptomatic P. vivax malaria

    doi: 10.1038/s44320-025-00135-z

    Figure Lengend Snippet: Peripheral blood mononuclear cells from P. vivax symptomatic ( n = 8), asymptomatic ( n = 8), and healthy controls ( n = 8) were stained with a panel of metal-labeled antibodies and analyzed CyTOF. ( A ) Manual gating was used to select for CD14 + monocytes. ( B ) vi-SNE analysis was performed on pooled monocytes for each group and the cell surface expression was illustrated by their density.

    Article Snippet: 160 Gd-conjugated mouse anti-human CD14 , Fluidigm , Clone RMO52, Cat.# 3160006B.

    Techniques: Staining, Labeling, Expressing

    ( A – F ) PBMCs from P. vivax symptomatic ( n = 8) and asymptomatic ( n = 8) infected individuals as well as healthy immune controls ( n = 8) were stained with a panel of metal-labeled antibodies and analyzed by CyTOF. ( A ) t-SNE analysis was performed on CD14 + CD3 - CD29 - monocytes. Plots display cell density and represent the pooled data for each group. ( B ) Projection of FlowSOM clusters on a t-SNE plot. ( C ) Heatmaps show the median marker expression for each FlowSOM cluster. ( D – F ) Unsupervised identification of differentially abundant populations between clinical groups was performed using CITRUS (FDR < 5%) between clinical groups. Panels on the top left or each panel show differentially abundant populations on a t-SNE overlay identified as follows: significantly more abundant in symptomatic individuals compared to healthy immune controls ( D ), significantly more abundant in symptomatic and asymptomatic individuals compared to healthy immune controls ( E ) and significantly depleted in symptomatic and asymptomatic individuals compared to healthy immune controls ( F ). vi-SNE plots on the top right-hand side or each top panel depict relevant marker expression on t-SNE overlays. The lower left panels show the frequency of differentially abundant cell populations identified by CITRUS. Boxes represent the 25th to 75th percentile, whiskers show the range (minimum to maximum), and lines represent the median of 8 symptomatic, 8 asymptomatic, and 8 healthy immune control biological replicates. The lower right panels illustrate marker expression in differentially abundant populations (pink histograms), relative to background expression (lilac histograms).

    Journal: Molecular Systems Biology

    Article Title: Systems approach identifies monocyte imbalance in symptomatic and asymptomatic P. vivax malaria

    doi: 10.1038/s44320-025-00135-z

    Figure Lengend Snippet: ( A – F ) PBMCs from P. vivax symptomatic ( n = 8) and asymptomatic ( n = 8) infected individuals as well as healthy immune controls ( n = 8) were stained with a panel of metal-labeled antibodies and analyzed by CyTOF. ( A ) t-SNE analysis was performed on CD14 + CD3 - CD29 - monocytes. Plots display cell density and represent the pooled data for each group. ( B ) Projection of FlowSOM clusters on a t-SNE plot. ( C ) Heatmaps show the median marker expression for each FlowSOM cluster. ( D – F ) Unsupervised identification of differentially abundant populations between clinical groups was performed using CITRUS (FDR < 5%) between clinical groups. Panels on the top left or each panel show differentially abundant populations on a t-SNE overlay identified as follows: significantly more abundant in symptomatic individuals compared to healthy immune controls ( D ), significantly more abundant in symptomatic and asymptomatic individuals compared to healthy immune controls ( E ) and significantly depleted in symptomatic and asymptomatic individuals compared to healthy immune controls ( F ). vi-SNE plots on the top right-hand side or each top panel depict relevant marker expression on t-SNE overlays. The lower left panels show the frequency of differentially abundant cell populations identified by CITRUS. Boxes represent the 25th to 75th percentile, whiskers show the range (minimum to maximum), and lines represent the median of 8 symptomatic, 8 asymptomatic, and 8 healthy immune control biological replicates. The lower right panels illustrate marker expression in differentially abundant populations (pink histograms), relative to background expression (lilac histograms).

    Article Snippet: 160 Gd-conjugated mouse anti-human CD14 , Fluidigm , Clone RMO52, Cat.# 3160006B.

    Techniques: Infection, Staining, Labeling, Marker, Expressing, Control

    KEY RESOURCES TABLE

    Journal: Cell

    Article Title: NKG2A blockade potentiates CD8 T-cell immunity induced by cancer vaccines

    doi: 10.1016/j.cell.2018.10.028

    Figure Lengend Snippet: KEY RESOURCES TABLE

    Article Snippet: CD14 – 160 Gd (M5E2) , Fluidigm , Prod#: 3151009B.

    Techniques: Blocking Assay, Purification, Virus, Recombinant, Staining, Transfection, Cell Stimulation, Adjuvant, Mutagenesis, Transgenic Assay, Marker, Sequencing, Expressing, Plasmid Preparation, Software, CRISPR